drugset / Trial / NCT02163278
A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects
RandomizedSingle-groupTriple-blindTreatment
Summary
The study is being performed to assess the safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) properties of multiple oral doses of DBPR108 in healthy male subjects.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DBPR108 | Small molecule | 25 mg | Oral |
| Subject | DBPR108 | Small molecule | 600 mg | Oral |